Last updated: 2026-10-15 21:05:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Lexicon Pharmaceuticals, Inc. (LXRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.65, with a market capitalization of $716.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.10 to $2.68. This page covers its latest market performance, valuation, price trends and company information.
$716.38M | |
$1.65 | |
$28.21 | |
$0.28 | |
$1.60 | |
376.49K | |
2.87M | |
-- | |
$2.68 | |
$1.10 | |
-- | |
-- |
Lexicon Pharmaceuticals, Inc. (LXRX) is trading at $1.65 in after-hours trading as of 2026-10-15 20:57:00, up 2.81% ($0.04) from the regular-session close of $1.60.
After-hours trading shows how investors are pricing LXRX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Lexicon Pharmaceuticals, Inc. (LXRX) moved from $1.75 to $1.65, representing a decline of 6.00% ($0.10).
The stock traded between $1.56 and $1.78 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 2.02 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 34.5%
LXRX is currently trading at $1.65, placing it 34.5% of the way from its 52-week low of $1.10 to its 52-week high of $2.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 81 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lexicon Pharmaceuticals, Inc. (LXRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.